Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: April 2008
-
By Kevin E. Noonan — The penchant for The New York Times‘ anti-innovation editorial policies to seamlessly blend into its "news" coverage (particularly on the Business page) has been noted by Patent Docs before. Whether the latest example is more egregious than in the past is a matter of debate, but with apologies…
-
By Donald Zuhn — On Monday, Neuralstem, Inc. announced that the European Patent Office had granted European Patent No. EP 0 915 968 to the Rockville, Maryland-based biotech company. The ‘968 patent, entitled, "Isolation, Propagation and Directed Differentiation of Stem Cells from Embryonic and Adult Central Nervous System of Mammals," is directed to…
-
By Kevin E. Noonan — The U.S. Trade representative issued a "Special 301 Report" on Monday, pursuant to the provisions of the Trade Act of 1974. This report, on the state of intellectual property rights worldwide, identifies twelve countries on a "priority watch list" and promises consultations with Congress, affected industry groups, and…
-
By Christopher P. Singer — According to an April 28, 2008 press release, the U.S. Patent and Trademark Office (USPTO) and the European Patent Office (EPO) will implement a one-year long pilot Patent Prosecution Highway (PPH) program starting in September 2008. Similar pilot programs with other countries have demonstrated the potential of the…
-
By Donald Zuhn — Last Tuesday, GlaxoSmithKline and Sirtris Pharmaceuticals announced that the companies had entered into a definitive agreement under which GlaxoSmithKline would acquire Sirtris Pharmaceuticals for approximately $720 million. The acquisition is motivated by GSK’s desire to enhance its metabolic, neurology, immunology, and inflammation research efforts by utilizing Sirtris’ expertise in…
-
By Donald Zuhn — Last fall, we reported on a memorandum of understanding that the U.S. Patent and Trademark Office (USPTO), European Patent Office (EPO), and Japan Patent Office (JPO) had reached during the 25th Annual Trilateral Conference. One aspect of this agreement concerned a Common Application Format (CAF), which would allow applicants…
-
By Kevin E. Noonan — In rendering its decision in eBay Inc. v. MercExchange, L.L.C. that the Federal Circuit’s rubric that a patentee victory in a patent infringement lawsuit rendered the grant of a permanent injunction against the defendant almost "automatic," it is likely that the Supreme Court intended merely to adhere more…
-
By Christopher P. Singer — The Intellectual Property Owners Association (IPO) recently published a letter in opposition to the Federal Register Notice outlining proposed rule changes regarding biological deposits (see "Proposed Rule Change to Timing of Filing a Biological Deposit"). In particular, in its letter, signed by President Steven W. Miller, the IPO…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. UCB Inc. et al. v. KV Pharmaceutical Co.1:08-cv-00223; filed April 18, 2008 in the District Court of Delaware Infringement of U.S. Patent…
-
April 25, 2008 – Patent Claim Construction (Law Seminars International) – Atlanta, GA April 30, 2008 – Public PAIR and Data-Mining Requests Webcast (U.S. Patent and Trademark Office) April 30-May 1, 2008 – Pharma/Biotech Collaborative Agreements (American Conference Institute) – San Francisco, CA May 15, 2008 – The Federal Circuit: A National Court of Appeals:…
Patent Docs 